Recommendations for the peri-operative management of patients taking sodium-glucose cotransporter-2 inhibitors [1] : The risk of peri-operative ketoacidosis and mitigation strategies should be discussed with the patient using a shared decision-making approach." "Sodium-glucose cotransporter-2 inhibitors should be omitted the day before and the day of a procedure
Tirzepatide reduced blood glucose levels and led to weight loss in humans, and therefore, tirzepatide was used successfully against obesity in humans (Jastreboff et al
However, the mechanistic improvements that underlie cardiovascular protection begin much earlier
Plus, you avoid the discomfort of weekly injections
Different peptides work through separate pathways, so stacking them can offer broader and more noticeable results than using a single peptide alone
Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study